SMS Pharmaceuticals Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

210.45

242.43

196.05

248.20

173.35

196.75

164.45

Other Operating Income

0.00

Total Operating income

210.45

242.43

196.05

248.20

173.35

196.75

164.45

Raw Material Cost

139.19

106.56

146.66

117.54

118.32

158.77

107.24

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

-25.43

33.26

-35.69

30.37

-32.83

-43.08

-19.28

Employee Cost

21.05

19.25

18.18

26.63

18.64

17.93

16.88

Power Cost

0.00

Manufacturing Expenses

21.80

25.74

19.73

25.41

20.75

22.00

18.20

Selling and Distribution Expenses

0.00

Other Expenses

10.19

9.26

7.80

7.44

15.26

9.66

7.90

Total Expenditure (Excl Depreciation)

166.80

194.07

156.68

207.39

140.14

165.28

130.94

Operating Profit (PBDIT) excl Other Income

43.65

48.36

39.37

40.81

33.21

31.47

33.51

Other Income

3.75

1.43

0.59

1.42

2.13

1.30

1.37

Operating Profit (PBDIT)

47.40

49.79

39.96

42.23

35.34

32.77

34.88

Interest

6.22

5.74

5.84

5.07

4.20

4.61

4.67

Exceptional Items

0.00

Gross Profit (PBDT)

41.18

44.05

34.12

37.16

31.14

28.16

30.21

Depreciation

10.02

9.75

8.64

8.70

8.62

8.38

Profit Before Tax

31.16

34.04

24.37

28.52

22.44

19.54

21.83

Tax

7.97

8.91

5.65

8.44

5.36

5.68

5.46

Provisions and contingencies

0.00

Profit After Tax

23.19

25.13

18.71

20.08

17.08

13.86

16.37

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

23.19

25.13

18.71

20.08

17.08

13.86

16.37

Share in Profit of Associates

0.28

0.18

1.78

0.23

1.16

0.24

0.10

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

23.47

25.31

20.49

20.32

18.24

14.10

16.48

Equity Capital

9.37

8.87

8.47

Face Value

1.0

Reserves

0.00

Earnings per share (EPS)

2.5

2.7

2.31

2.29

2.15

1.66

1.95

Diluted Earnings per share

2.59

2.84

2.31

2.4

2.15

1.67

1.95

Operating Profit Margin (Excl OI)

20.74%

19.95%

20.08%

16.44%

19.16%

15.99%

20.38%

Gross Profit Margin

19.57%

18.17%

17.4%

14.97%

17.96%

14.31%

18.37%

PAT Margin

11.02%

10.37%

9.54%

8.09%

9.85%

7.04%

9.95%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is -13.19% vs 23.66% in Sep 2025

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -7.27% vs 23.52% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -9.74% vs 22.83% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is 8.36% vs -1.71% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of SMS Pharma. With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

210.45

521.17

-310.72

-59.62%

Other Operating Income

0.00

Total Operating income

210.45

521.17

-310.72

-59.62%

Raw Material Cost

139.19

174.26

-35.07

-20.13%

Purchase of Finished goods

0.00

48.93

-48.93

-100.00%

(Increase) / Decrease In Stocks

-25.43

13.91

-39.34

-282.82%

Employee Cost

21.05

99.27

-78.22

-78.80%

Power Cost

0.00

Manufacturing Expenses

21.80

0.00

21.80

Selling and Distribution Expenses

0.00

Other Expenses

10.19

140.02

-129.83

-92.72%

Total Expenditure (Excl Depreciation)

166.80

476.39

-309.59

-64.99%

Operating Profit (PBDIT) excl Other Income

43.65

44.78

-1.13

-2.52%

Other Income

3.75

11.80

-8.05

-68.22%

Operating Profit (PBDIT)

47.40

56.58

-9.18

-16.22%

Interest

6.22

7.42

-1.20

-16.17%

Exceptional Items

0.00

275.52

-275.52

-100.00%

Gross Profit (PBDT)

41.18

324.68

-283.50

-87.32%

Depreciation

10.02

31.25

-21.23

-67.94%

Profit Before Tax

31.16

293.43

-262.27

-89.38%

Tax

7.97

29.14

-21.17

-72.65%

Provisions and contingencies

0.00

Profit After Tax

23.19

264.29

-241.10

-91.23%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

23.19

264.29

-241.10

-91.23%

Share in Profit of Associates

0.28

0.00

0.28

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

23.47

264.29

-240.82

-91.12%

Equity Capital

9.37

14.08

-4.71

-33.45%

Face Value

1.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

2.50

37.54

-35.04

-93.34%

Diluted Earnings per share

2.59

37.47

-34.88

-93.09%

Operating Profit Margin (Excl OI)

20.74%

8.59%

0.00

12.15%

Gross Profit Margin

19.57%

62.30%

0.00

-42.73%

PAT Margin

11.02%

50.71%

0.00

-39.69%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 210.45 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -13.19% vs 23.66% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 21.40% vs 7.35% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 23.47 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -7.27% vs 23.52% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 28.67% vs 58.89% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 43.65 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -9.74% vs 22.83% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 31.44% vs 14.52% in Dec 2024

Quarterly - Interest

Interest 6.22 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 8.36% vs -1.71% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 48.10% vs -29.41% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 20.74%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024